LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 14

Search options

  1. Article ; Online: Discovery of Pyrazolo[1,5-a]pyrazin-4-ones as Potent and Brain Penetrant GluN2A-Selective Positive Allosteric Modulators Reducing AMPA Receptor Binding Activity.

    Sakurai, Fumie / Yukawa, Takafumi / Kina, Asato / Murakami, Masataka / Takami, Kazuaki / Morimoto, Sachie / Seto, Masaki / Kamata, Makoto / Yamashita, Tohru / Nakashima, Kosuke / Narita, Naohiro / Bettini, Ezio / Ugolini, Annarosa / Corsi, Mauro / Hasui, Tomoaki

    Bioorganic & medicinal chemistry

    2021  Volume 56, Page(s) 116576

    Abstract: N-Methyl-d-aspartate receptors (NMDARs) are members of the ionotropic glutamate receptor family and play a crucial role in learning and memory by regulating synaptic plasticity. Activation of NMDARs containing GluN2A, one of the NMDAR subunits, has ... ...

    Abstract N-Methyl-d-aspartate receptors (NMDARs) are members of the ionotropic glutamate receptor family and play a crucial role in learning and memory by regulating synaptic plasticity. Activation of NMDARs containing GluN2A, one of the NMDAR subunits, has recently attracted attention as a promising therapeutic approach for neuropsychiatric diseases such as schizophrenia, depression, and epilepsy. In the present study, we developed potent and brain-penetrable GluN2A-selective positive allosteric modulators. Lead compound 2b was generated by scaffold hopping of hit compound 1, identified from the internal alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR)-focused compound library through a high-throughput screening campaign. Subsequent optimization of the lead compound, including a structure-based drug design approach, resulted in the identification of a potent GluN2A PAM (R)-9, which possessed high selectivity against both subtypes of AMPAR and NMDAR. Furthermore, (R)-9 significantly enhanced long-term potentiation in the rat hippocampus 24 h after oral administration, indicating that this molecule is a potentially useful in vivo pharmacological tool for treating psychiatric diseases.
    MeSH term(s) Administration, Oral ; Allosteric Regulation/drug effects ; Animals ; Binding Sites/drug effects ; Brain/metabolism ; Crystallography, X-Ray ; Dose-Response Relationship, Drug ; Drug Discovery ; Injections, Intravenous ; Male ; Molecular Docking Simulation ; Molecular Structure ; Rats ; Rats, Sprague-Dawley ; Receptors, AMPA/metabolism ; Receptors, N-Methyl-D-Aspartate/metabolism ; Structure-Activity Relationship
    Chemical Substances Receptors, AMPA ; Receptors, N-Methyl-D-Aspartate ; N-methyl D-aspartate receptor subtype 2A (VH92ICR8HX)
    Language English
    Publishing date 2021-12-16
    Publishing country England
    Document type Journal Article
    ZDB-ID 1161284-8
    ISSN 1464-3391 ; 0968-0896
    ISSN (online) 1464-3391
    ISSN 0968-0896
    DOI 10.1016/j.bmc.2021.116576
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Discovery of a novel series of GPR119 agonists: Design, synthesis, and biological evaluation of N-(Piperidin-4-yl)-N-(trifluoromethyl)pyrimidin-4-amine derivatives.

    Kubo, Osamu / Takami, Kazuaki / Kamaura, Masahiro / Watanabe, Koji / Miyashita, Hirohisa / Abe, Shinichi / Matsuda, Kae / Tsujihata, Yoshiyuki / Odani, Tomoyuki / Iwasaki, Shinji / Kitazaki, Tomoyuki / Murata, Toshiki / Sato, Kenjiro

    Bioorganic & medicinal chemistry

    2021  Volume 41, Page(s) 116208

    Abstract: We undertook an optimization effort involving propan-2-yl 4-({6-[5-(methanesulfonyl)-2,3-dihydro-1H-indol-1-yl]pyrimidin-4-yl}oxy)piperidine-1-carboxylate 1, which we had previously discovered as a novel G protein-coupled receptor 119 (GPR119) agonist. ... ...

    Abstract We undertook an optimization effort involving propan-2-yl 4-({6-[5-(methanesulfonyl)-2,3-dihydro-1H-indol-1-yl]pyrimidin-4-yl}oxy)piperidine-1-carboxylate 1, which we had previously discovered as a novel G protein-coupled receptor 119 (GPR119) agonist. To occupy a presumed hydrophobic space between the pyrimidine and piperidine rings in interaction with GPR119, we replaced the linker oxygen with nitrogen. Subsequently, the introduction of a substituent at the bridging nitrogen atom was explored. We found that the installation of N-trifluoromethyl group 10 not only enhanced GPR119 agonist activity but also considerably improved the human ether-à-go-go-related gene (hERG) inhibition profile. These improvements were not observed for non-fluorinated substituents, such as ethyl analog 8b. The next optimization effort focused on the exploration of a new surrogate structure for the indoline ring and the isosteric replacements of the piperidine N-Boc group to improve solubility, metabolic stability, and oral bioavailability. As a result, N-{1-[3-(2-fluoropropan-2-yl)-1,2,4-oxadiazol-5-yl]piperidin-4-yl}-6-{[1-(methanesulfonyl)piperidin-4-yl]oxy}-N-(trifluoromethyl)pyrimidin-4-amine (27) was identified as a potent and orally bioavailable GPR119 agonist. This compound augmented insulin secretion and effectively lowered plasma glucose excursion in a diabetic animal model after oral administration. In this study, we discuss the designs, syntheses, and biological activities of a novel series of N-(piperidin-4-yl)-N-(trifluoromethyl)pyrimidin-4-amine derivatives as GPR119 agonists, and to determine the distinctive effect of the N-trifluoromethyl group on hERG inhibition, we also discuss the conformational preference of representative compounds.
    MeSH term(s) Amines/chemistry ; Amines/pharmacology ; Animals ; Area Under Curve ; Blood Glucose ; Diabetes Mellitus, Experimental/drug therapy ; Drug Design ; Drug Discovery ; Gene Expression Regulation/drug effects ; Hypoglycemic Agents/chemistry ; Hypoglycemic Agents/pharmacology ; Insulin/metabolism ; Molecular Structure ; Rats ; Receptors, G-Protein-Coupled/genetics ; Receptors, G-Protein-Coupled/metabolism
    Chemical Substances Amines ; Blood Glucose ; GPR119 protein, rat ; Hypoglycemic Agents ; Insulin ; Receptors, G-Protein-Coupled
    Language English
    Publishing date 2021-05-09
    Publishing country England
    Document type Journal Article
    ZDB-ID 1161284-8
    ISSN 1464-3391 ; 0968-0896
    ISSN (online) 1464-3391
    ISSN 0968-0896
    DOI 10.1016/j.bmc.2021.116208
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Discovery of a novel series of medium-sized cyclic enteropeptidase inhibitors.

    Kikuchi, Fumiaki / Ikeda, Zenichi / Kakegawa, Keiko / Nishikawa, Youichi / Sasaki, Shigekazu / Fukuda, Koichiro / Takami, Kazuaki / Banno, Yoshihiro / Nishikawa, Hitoaki / Taya, Naohiro / Nakahata, Takashi / Itono, Sachiko / Yashiro, Hiroaki / Tsuchimori, Kazue / Hiyoshi, Hideyuki / Sasaki, Masako / Tohyama, Kimio / Matsumiya, Kouta / Ishihara, Youko /
    Kawamoto, Tetsuji / Kamaura, Masahiro / Watanabe, Masanori / Kitazaki, Tomoyuki / Maekawa, Tsuyoshi / Sasaki, Minoru

    Bioorganic & medicinal chemistry

    2023  Volume 93, Page(s) 117462

    Abstract: Enteropeptidase is located in the duodenum that involved in intestinal protein digestion. We have reported enteropeptidase inhibitors with low systemic exposure. The aim of this study was to discover novel enteropeptidase inhibitors showing more potent ... ...

    Abstract Enteropeptidase is located in the duodenum that involved in intestinal protein digestion. We have reported enteropeptidase inhibitors with low systemic exposure. The aim of this study was to discover novel enteropeptidase inhibitors showing more potent in vivo efficacy while retaining low systemic exposure. Inhibitory mechanism-based drug design led us to cyclize ester 2 to medium-sized lactones, showing potent enteropeptidase inhibitory activity and improving the ester stability, thus increasing fecal protein output in vivo. Optimization on the linker between two benzene rings resulted in discovery of ether lactone 6b, exhibiting further enhanced enteropeptidase inhibitory activity and long duration of inhibitory state. Oral administration of 6b in mice significantly elevated fecal protein output compared with the lead 2. In addition, 6b showed low systemic exposure along with low intestinal absorption. Furthermore, we identified the 10-membered lactonization method for scale-up synthesis of 6b, which does not require high-dilution conditions.
    MeSH term(s) Animals ; Mice ; Enteropeptidase ; Administration, Oral ; Drug Design ; Esters ; Ethers ; Lactones/pharmacology
    Chemical Substances Enteropeptidase (EC 3.4.21.9) ; Esters ; Ethers ; Lactones
    Language English
    Publishing date 2023-08-29
    Publishing country England
    Document type Journal Article
    ZDB-ID 1161284-8
    ISSN 1464-3391 ; 0968-0896
    ISSN (online) 1464-3391
    ISSN 0968-0896
    DOI 10.1016/j.bmc.2023.117462
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Discovery of Brain-Penetrant Glucosylceramide Synthase Inhibitors with a Novel Pharmacophore.

    Tanaka, Yuta / Seto, Masaki / Kakegawa, Keiko / Takami, Kazuaki / Kikuchi, Fumiaki / Yamamoto, Takeshi / Nakamura, Minoru / Daini, Masaki / Murakami, Masataka / Ohashi, Tomohiro / Kasahara, Takahito / Wang, Junsi / Ikeda, Zenichi / Wada, Yasufumi / Puenner, Florian / Fujii, Takahiro / Inazuka, Masakazu / Sato, Sho / Suzaki, Tomohiko /
    Oak, Jeong-Ho / Takai, Yuichi / Kohara, Hiroshi / Kimoto, Kouya / Oki, Hideyuki / Mikami, Satoshi / Sasaki, Minoru

    Journal of medicinal chemistry

    2022  Volume 65, Issue 5, Page(s) 4270–4290

    Abstract: Inhibition of glucosylceramide synthase (GCS) is a major therapeutic strategy for Gaucher's disease and has been suggested as a potential target for treating Parkinson's disease. Herein, we report the discovery of novel brain-penetrant GCS inhibitors. ... ...

    Abstract Inhibition of glucosylceramide synthase (GCS) is a major therapeutic strategy for Gaucher's disease and has been suggested as a potential target for treating Parkinson's disease. Herein, we report the discovery of novel brain-penetrant GCS inhibitors. Assessment of the structure-activity relationship revealed a unique pharmacophore in this series. The lipophilic ortho-substituent of aromatic ring A and the appropriate directionality of aromatic ring B were key for potency. Optimization of the absorption, distribution, metabolism, elimination, toxicity (ADMETox) profile resulted in the discovery of
    MeSH term(s) Animals ; Brain/metabolism ; Gaucher Disease/drug therapy ; Gaucher Disease/metabolism ; Glucosylceramides/metabolism ; Glucosylceramides/therapeutic use ; Glucosyltransferases/metabolism ; Glucosyltransferases/therapeutic use ; Mice
    Chemical Substances Glucosylceramides ; Glucosyltransferases (EC 2.4.1.-) ; ceramide glucosyltransferase (EC 2.4.1.80)
    Language English
    Publishing date 2022-02-21
    Publishing country United States
    Document type Journal Article
    ZDB-ID 218133-2
    ISSN 1520-4804 ; 0022-2623
    ISSN (online) 1520-4804
    ISSN 0022-2623
    DOI 10.1021/acs.jmedchem.1c02078
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Design and Identification of a GPR40 Full Agonist (

    Furukawa, Hideki / Miyamoto, Yasufumi / Hirata, Yasuhiro / Watanabe, Koji / Hitomi, Yuko / Yoshitomi, Yayoi / Aida, Jumpei / Noguchi, Naoyoshi / Takakura, Nobuyuki / Takami, Kazuaki / Miwatashi, Seiji / Hirozane, Yoshihiko / Hamada, Teruki / Ito, Ryo / Ookawara, Mitsugi / Moritoh, Yusuke / Watanabe, Masanori / Maekawa, Tsuyoshi

    Journal of medicinal chemistry

    2020  Volume 63, Issue 18, Page(s) 10352–10379

    Abstract: GPR40/FFAR1 is a G-protein-coupled receptor expressed in pancreatic β-cells and enteroendocrine cells. GPR40 activation stimulates secretions of insulin and incretin, both of which are the pivotal regulators of glycemic control. Therefore, a GPR40 ... ...

    Abstract GPR40/FFAR1 is a G-protein-coupled receptor expressed in pancreatic β-cells and enteroendocrine cells. GPR40 activation stimulates secretions of insulin and incretin, both of which are the pivotal regulators of glycemic control. Therefore, a GPR40 agonist is an attractive target for the treatment of type 2 diabetes mellitus. Using the reported biaryl derivative
    MeSH term(s) Animals ; Benzamides/chemical synthesis ; Benzamides/pharmacokinetics ; Benzamides/therapeutic use ; CHO Cells ; Cricetulus ; Diabetes Mellitus, Experimental/drug therapy ; Hypoglycemic Agents/chemical synthesis ; Hypoglycemic Agents/pharmacokinetics ; Hypoglycemic Agents/therapeutic use ; Male ; Mice, Inbred ICR ; Molecular Structure ; Piperidines/chemical synthesis ; Piperidines/pharmacokinetics ; Piperidines/therapeutic use ; Rats, Sprague-Dawley ; Receptors, G-Protein-Coupled/agonists ; Structure-Activity Relationship
    Chemical Substances Benzamides ; Ffar1 protein, mouse ; G-protein-coupled receptor 40, rat ; Hypoglycemic Agents ; Piperidines ; Receptors, G-Protein-Coupled
    Language English
    Publishing date 2020-09-09
    Publishing country United States
    Document type Journal Article
    ZDB-ID 218133-2
    ISSN 1520-4804 ; 0022-2623
    ISSN (online) 1520-4804
    ISSN 0022-2623
    DOI 10.1021/acs.jmedchem.0c00843
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Stereoselective hydrothiolation of alkynes catalyzed by cesium base: facile access to (Z)-1-alkenyl sulfides.

    Kondoh, Azusa / Takami, Kazuaki / Yorimitsu, Hideki / Oshima, Koichiro

    The Journal of organic chemistry

    2005  Volume 70, Issue 16, Page(s) 6468–6473

    Abstract: Treatment of alkyne with alkanethiol in the presence of a catalytic amount of cesium carbonate and a radical inhibitor in DMSO provides the corresponding adduct, (Z)-1-alkenyl alkyl sulfide, in good yield with high selectivity. ...

    Abstract Treatment of alkyne with alkanethiol in the presence of a catalytic amount of cesium carbonate and a radical inhibitor in DMSO provides the corresponding adduct, (Z)-1-alkenyl alkyl sulfide, in good yield with high selectivity.
    Language English
    Publishing date 2005-08-05
    Publishing country United States
    Document type Journal Article
    ZDB-ID 123490-0
    ISSN 1520-6904 ; 0022-3263
    ISSN (online) 1520-6904
    ISSN 0022-3263
    DOI 10.1021/jo050931z
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Radical alkenylation of alpha-halo carbonyl compounds with alkenylindiums.

    Takami, Kazuaki / Yorimitsu, Hideki / Oshima, Koichiro

    Organic letters

    2004  Volume 6, Issue 24, Page(s) 4555–4558

    Abstract: Alkenylation reaction of alpha-halo carbonyl compounds with alkenylindiums proceeded via a radical process in the presence of triethylborane. Unactivated alkene moieties as well as a styryl group could be introduced by this method. The geometry of the ... ...

    Abstract Alkenylation reaction of alpha-halo carbonyl compounds with alkenylindiums proceeded via a radical process in the presence of triethylborane. Unactivated alkene moieties as well as a styryl group could be introduced by this method. The geometry of the carbon-carbon double bonds of the alkenylindiums was retained. Preparation of an alkenylindium via a hydroindation of 1-alkyne followed by radical alkenylation established an efficient one-pot strategy. [reaction: see text]
    Language English
    Publishing date 2004-11-25
    Publishing country United States
    Document type Journal Article
    ISSN 1523-7060
    ISSN 1523-7060
    DOI 10.1021/ol048070o
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Trans-hydrometalation of alkynes by a combination of InCl3 and DIBAL-H: one-pot access to functionalized (Z)-alkenes.

    Takami, Kazuaki / Yorimitsu, Hideki / Oshima, Koichiro

    Organic letters

    2002  Volume 4, Issue 17, Page(s) 2993–2995

    Abstract: reaction: see text] Triethylborane-induced hydrometalation of alkynes proceeds in an anti manner to afford the corresponding (Z)-alkenylmetal compounds stereoselectively, where dichloroindium hydride would play a key role. A variety of functional groups ...

    Abstract [reaction: see text] Triethylborane-induced hydrometalation of alkynes proceeds in an anti manner to afford the corresponding (Z)-alkenylmetal compounds stereoselectively, where dichloroindium hydride would play a key role. A variety of functional groups including hydroxy, carbonyl, and carboxy groups were tolerant under the reaction conditions. Following iodolysis and cross-coupling reaction of the (Z)-alkenylmetal species show the usefulness of this strategy.
    Language English
    Publishing date 2002-05-20
    Publishing country United States
    Document type Journal Article
    ISSN 1523-7060
    ISSN 1523-7060
    DOI 10.1021/ol026401w
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Discovery of Novel 5-(Piperazine-1-carbonyl)pyridin-2(1

    Mizojiri, Ryo / Nakata, Daisuke / Satoh, Yoshihiko / Morishita, Daisuke / Shibata, Sachio / Iwatani-Yoshihara, Misa / Kosugi, Yohei / Kosaka, Mai / Takeda, Junpei / Sasaki, Shigekazu / Takami, Kazuaki / Fukuda, Koichiro / Kamaura, Masahiro / Sasaki, Shinobu / Arai, Ryosuke / Cary, Douglas R / Imaeda, Yasuhiro

    ACS medicinal chemistry letters

    2017  Volume 8, Issue 10, Page(s) 1077–1082

    Abstract: Starting from our previous eIF4A3-selective ... ...

    Abstract Starting from our previous eIF4A3-selective inhibitor
    Language English
    Publishing date 2017-09-08
    Publishing country United States
    Document type Journal Article
    ISSN 1948-5875
    ISSN 1948-5875
    DOI 10.1021/acsmedchemlett.7b00283
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Reaction of silyldihalomethyllithiums with nitriles: formation of alpha-keto acylsilanes via azirines and 1,3-rearrangement of silyl group from C to N.

    Yagi, Kazunari / Tsuritani, Takayuki / Takami, Kazuaki / Shinokubo, Hiroshi / Oshima, Koichiro

    Journal of the American Chemical Society

    2004  Volume 126, Issue 28, Page(s) 8618–8619

    Abstract: A synthesis of alpha-keto acylsilanes, where 2-bromo-2H-azirine participates as a key intermediate, is reported. The reaction of silyldibromomethyllithium with aryl nitriles provides alpha-keto acylsilanes in good yields. Interestingly, ... ...

    Abstract A synthesis of alpha-keto acylsilanes, where 2-bromo-2H-azirine participates as a key intermediate, is reported. The reaction of silyldibromomethyllithium with aryl nitriles provides alpha-keto acylsilanes in good yields. Interestingly, silyldichloromethyllithium induces aza-1,3-Brook rearrangement of the silyl group in th reaction with nitriles. The rearrangement enables a three-component coupling reaction in a one-pot operation.
    Language English
    Publishing date 2004-07-21
    Publishing country United States
    Document type Journal Article
    ZDB-ID 3155-0
    ISSN 1520-5126 ; 0002-7863
    ISSN (online) 1520-5126
    ISSN 0002-7863
    DOI 10.1021/ja047708o
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top